Mice expressing human but not murine β3-adrenergic receptors under the control of human gene regulatory elements

Diabetes

Volumn 47, Issue 9, 1998, Pages 1464-1471

  Ito, Moriko ^a   Grujic, Danica ^a   Dale Abel, E ^a   Vidal Puig, Antonio ^a   Susulic, Vedrana S ^a   Lawitts, Joel ^a   Harper, Mary Ellen ^b   Himins Hagen, Jean ^b   Donny Strosberg, A ^c   Lowell, Bradford B ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CNRS   (France)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENERGY EXPENDITURE; GENE CONTROL; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0031711336     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1464     Document Type: Article

References (39)

1. Bloom JD, Dutia MD, Johnson BD, Wissner A, Burns MG, Largis EE, Dolan JA, Claus TH: Disodium (R,R)-5-. J Med Chem 35:3081-3084, 1992
2. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S: Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163-165, 1984
3. S. Holloway BR, Howe R, Rao BS, Stribling D: ICID7114: a novel selective adrenoceptor agonist of brown fat and thermogenesis. Am J Clin Nutr 55:262S-264S, 1992
4. 3-adrenergic receptor. Science 245:1118-1121, 1989
5. 3-adrenergic receptor. Mol PharmacoL 40:896-899, 1991
6. Muzzin P. Revelli JP, Kuhne F, Gocayne JD, McCombie WR Venter JC. Giacobino JP, Fraser CM: An adipose tissue-specific β-adrenergic receptor molecular cloning and downregulation in obesity. J Biol Chem 266:24053-24058, 1991
7. 3-adrenergic receptor relationship with the atypical receptor of adipocytes. Embo J 10:3721-3727, 1991
8. Granneman JG, Lahners KN, Rao DD: Rodent and human β-adrenergic receptor genes contain an intron within the protein-coding block. Mol Pharmocol 42:964-970, 1992
9. 3-adrenergic receptor? Cell Signal 7:9-15, 1995
10. 3-adrenergic receptor messenger ribonucleic acids. Endocrinology 135:1025-1031, 1994
11. 3adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
12. 3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228, 1995
13. 3-adrenergic receptor in human white adipose tissue. J Mol Endocrinol 10:193-197, 1993
14. 3 adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol 43:343-348, 1993
15. 3-adrenoceptor in man. J Clin Invest 95:2239-2245, 1995
16. Lonnqyist F, Krief S, Strosberg SD, Nyberg S, Emorine LJ, Arner P: Evidence for a functional 3-adrenoceptor in man. Br JPkarmacol 110:929-936, 1993
17. 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int J Obes Relat Metab Disord 20:428-434, 1996
18. 3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J Lipid. Res 37:87-97, 1996
19. 3 adrenergic effect on lipolysis in human subcutaneous adipose tissue. J Clin Endocrinol Metab 77:352-355, 1993
20. 3-adrenoceptor. Br J Pharmacol 122:1244-1250, 1997
21. 3-adrerioceptor. Br J Pharmacol 112:911-919, 1994
22. Dolan JA, Muenkel HA, Burns MG, Pellegrino SM, Fraser CM, Pietri F, Strosberg AD, Largis EE, Dutia MD, Bloom JD, Bass AS, Tanikella TK, Cobuzzi A, Fong M, Claus TH: Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Exp Ther 269:1000-1006, 1994
23. 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int J Obes Relat Metab Disord 20:191-199, 1996
24. 3-adrenoceptor agonists in the treatment of obesity and diabetes. Curr Opin Endocrin Diabetes 3:59-65, 1996
25. 3-adrenergic receptor gene. J Biol Chem 270:29483-29492, 1995
26. 3-adrenoceptor in the regulation of body composition. J Clin Invest 100:1098-1106, 1997
27. 3-adrenergic receptor genes. Eur J Biochem 213:1117-1124, 1993
28. Hogan B, Beddington T, Costnatini F, Lacy E: Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1994
29. Gu H, Zou Y-R, Rajewsky K: Independent control of immunoglobulin switch recombination at individual switch regions evidenced through CreloxP-mediated gene targeting. Cell 73:1155-1164, 1993
30. Jakubowski M, Roberts JL: Processing of gonadotropin-releasing hormone gene transcripts in the rat brain. J Biol Chem 269:4078-4083, 1994
31. 3 and atypical β-adrenergic receptors cause redundant increases in cyclic AMP in human neuroblastoma cells. Mol Pharmacol 42:753-759, 1992
32. Kaumann AJ: Four β-adrenoceptor subtypes in the mammalian heart. Trends Pharmacol Sci 18:70-76, 1997
33. Kaumann AJ, Molenaar P: Differences between the third cardiac β-adrenoceptor and the colonie β3-adrenoceptor in the rat. Br J Pharmacol 118:2085-2093, 1996
34. 3-adrenoceptors. Br J Pharmacol 117:943-949, 1996
35. Cawthorne MA, Sennitt MV, Arch JRS, Smith SA: BRL 35135, a potent and selective atypical β-adrenoceptor agonist Am J Clin Nutr 55:252S-257S, 1992
36. 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210-216, 1996
37. Grujic D, Susulic VS, Harper M-E, Himms-Hagen J, Cunningham BA, Corkey BE, Lowell BB: β3β-adrenergic receptors on white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. J Biol Chem 272:17686-17693, 1997
38. Fleury C, Neverova M, Collins S, Raimbailt S, Champigny O, Corinne L-M, Bouillaud F, Seldin MF, Surwitt RS, Ricquier D, Warden CH: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nature Genet 15:269-272, 1997
39. Gimeno RE, Dembski M, Weng X, Deng N, Shyjan AW, Gimeno CJ, Iris F, Ellis SJ, Woolf EA, Tartaglia LA: Cloning and characterization of an uncoupling protein homolog: a potential molecular mediator human thermogenesis. Diabetes 46:900-906, 1997